General AdvanceTranspose PlatformEntrepreneurs FirstMoonfire Ventures
Description
Pharosyn, a London-based AI startup, has raised $3 million in seed funding led by Moonfire Ventures, with participation from Entrepreneurs First, Transpose Platform, and General Advance. The company develops AI systems for pharmaceutical companies' commercial departments, enabling them to produce reports in 15 minutes instead of four hours. Pharosyn is collaborating with top-ten biopharmaceutical companies and mid-sized pharma firms on commercial and competitive intelligence. The funding will help the company address pharmaceutical companies' need for faster decision-making on pricing, market access, and portfolio management.
Company Information
Company
Pharosyn
Location
Greater London, England, United Kingdom
About
Pharosyn is a London-based AI startup that develops custom AI systems for pharmaceutical companies' commercial departments, focusing on commercial and competitive intelligence rather than drug discovery. The company's tools reduce report generation time from four hours to 15 minutes by tracking clinical, regulatory, and commercial data sources including trial data, deals, and hiring trends. Built on Cambridge research about mitigating hallucinations in large language models, Pharosyn emphasizes traceability and custom AI infrastructure embedded directly within commercial teams. The platform is used daily by senior executives at top-10 biopharmaceutical companies and mid-sized pharmaceutical firms to inform strategic decisions on pricing, market access, and portfolios.
Don't miss Pharosyn's next move
Get an email the moment Pharosyn raises, hires an exec, or expands, usually minutes after it happens.
Greater LondonBiotechnologyArtificial IntelligenceAnalyticsMachine Learning